SeanMatthewMcBrideMDMPH

Head & Neck, Urologic Cancer

Chief, Manhattan Service, Department of Radiation Oncology Associate Attending, Memorial Sloan Kettering Cancer Center

Overview of Dr. McBride

Dr. Sean McBride is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Yale School of Medicine and has been in practice 9 years. He is one of 110 doctors at Memorial Sloan Kettering Cancer Center and one of 26 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Radiation Oncology. He has more than 70 publications and over 500 citings.

Office
530 East 74th Street
New York, NY 10021
Book by Phone+1(231) 508-9908

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2009 - 2013
Harvard School of Public HealthMPH, 2011 - 2012
Sutter Health/California Pacific Medical CenterInternship, Internal Medicine, 2008 - 2009
Yale School of MedicineClass of 2008

Certifications & Licensure

FL State Medical License 2023 - Present
NY State Medical License 2013 - 2026
NJ State Medical License 2015 - 2025
MA State Medical License 2011 - 2014
American Board of Radiology Radiation Oncology

Clinical Trials

Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men with Newly Diagnosed Hormone-sensitive Prostate Cancer Start of enrollment: 2020 Mar 03
ACTIVE_NOT_RECRUITING
PHASE2
Roles: Contact

Publications & Presentations

PubMed

1 citations
Nasopharynx Cancer in the United States: Racial and Ethnic Disparities in Stage at Presentation.
Edward Christopher Dee, Stephanie Wang, Frances Dominique V Ho, Roshal R Patel, Kaitlyn Lapen
The Laryngoscope. 2025-03-01
Association Between Medicaid Expansion and Insurance Status, Risk Group, Receipt, and Refusal of Treatment Among Men with Prostate Cancer.
Tej A Patel, Bhav Jain, Edward Christopher Dee, Khushi Kohli, Sruthi Ranganathan
Cancers. 2025-02-06
Continued Promise and Possibility of Prospective Payment System Exemption: An Investment in the Future of Cancer Care Innovation.
Sean M McBride, Craig A Bunnell
JCO Oncology Practice. 2025-02-05

Lectures

Biomarker predictors of outcome from a randomized trial of nivolumab +/- stereotactic body radiotherapy (SBRT) in metastatic (M1) head and neck squamous cell carcinoma...
2019 ASCO Annual Meeting - 6/1/2019
Baseline genomic and circulating tumor cell (CTC) correlative data from very high-risk (VHR), localized, node-negative prostate cancer patients.
2019 ASCO Annual Meeting - 6/1/2019
Apalutamide + abiraterone + leuprolide with stereotactic, ultra-hypofractionated radiation (AASUR) in very high risk prostate cancer (PCa).
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HN...
2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
Join now to see all

Press Mentions

New MSK Radiation Approach Means Fewer Side Effects for More Patients with HPV-Related Head and Neck CancerJanuary 20th, 2022
‘Contrary’ to Wide Belief, Abscopal Effect Is Rare in CancerJanuary 7th, 2021
New SU2C Teams Accelerate Clinical Trials for Difficult Breast & Prostate CancersSeptember 16th, 2019
Join now to see all